BioGaia Reports 9% Sales Growth in 2016

a10c9b81-d886-4137-9cda-f4a798f3ec08articleimage.jpg

14 Feb 2017 --- Swedish probiotics manufacturer, BioGaia, has announced an annual sales growth of 9% in 2016 - a growth that the company is in part attributing to its continued success in the Asian market.

The company’s net sales amounted to SEK 534.7 million ($60 million) in 2016.

“Looking back at 2016, we can only feel satisfied,” says Axel Sjöblad, Managing Director of BioGaia AB.

“With sales growth of 9% excluding foreign exchange effects, we were able to pass the half billion mark and achieve annual sales of SEK 534.7 million ($60 million).”

“This enabled us to increase our market shares despite the fact that the sales to Brazil, one of our most important markets, were low as a result of the inventory build-up during 2015.”

“The operating profit, excluding the distributed former subsidiary IBT, reached SEK 199.4 million ($22.4 million), an increase of 14% excluding foreign exchange effects, which leads to an operating margin of 37%.”

“Our strong financial development, while we were building a platform for future growth and signing new distribution agreements in Japan and Thailand, demonstrates the strength of our business model, our employees and our products, and gives us reason to look to the future with continued confidence.”

Towards the end of Q4, BioGaia signed major agreements for the sale of BioGaia’s probiotic products in Japan, and the company also made a further investment in MetaboGen, a company researching the microbiome to understand health and disease, and creating opportunities to develop novel therapeutics and next generation probiotics.

And it looks like the year ahead is set to follow in 2016’s footsteps. So far in 2017, an agreement has been made for the sale of BioGaia’s products in Thailand, with the products being co-branded under BioGaia and Abbott brand.

“We have a strong focus on growing our Asian business and I am very pleased that BioGaia’s products will be available in another important country in the region,” says Axel Sjöblad.

“Based on the positive experience we already have in collaborating with Abbott in Latin America, I look forward to a successful launch of our products with Abbott in Thailand as well.”

Related Articles

Nutrition & Health News

Chronic Fatigue Syndrome Linked to Imbalanced Microbiome

26 Apr 2017 --- Scientists have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome (IBS). The findings come from researchers at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health.

Nutrition & Health News

SGS Approved to Audit Against the Gluten-Free Certification Organization Standard

26 Apr 2017 --- SGS, the world’s leading inspection, verification, testing and certification company has been approved as the first Certification Body to audit against the Gluten-Free Certification Organization (GFCO) standards covering all regions of the world.

Nutrition & Health News

Glanbia Introduces Lecithin-Free Agglomeration Technology

26 Apr 2017 --- Glanbia Nutritionals has announced a breakthrough patent-pending agglomeration technology called BevEdge for powdered drink mixes and liquid beverages. Entirely lecithin free, this method of agglomeration is based on an all-protein solution and can be applied to whey-based, milk-based, casein-based and plant-based ingredients, including hydrolysates. This flexibility provides both sports and lifestyle brands with significantly more opportunities to create highly marketable beverages. And with no lecithin, it is a perfect clean label solution.

Nutrition & Health News

Low Fat, High Sugar "Diet" Products Contribute to Weight Gain: US Study

26 Apr 2017 --- A new study has underscored the idea that low fat, high sugar "diet" foods play an important role in unwanted weight gain. Researchers from the University of Georgia found that rats fed a diet high in sugar but low in fat increased body fat mass when compared to rats fed a balanced (rodent) diet. Moreover, the rats fed a high-sugar diet were more likely to experience a range of other health problems, such as liver damage and brain inflammation.

Nutrition & Health News

Colitis Relieving Properties Turmeric Extract BCM-95 Underlined by Study

26 Apr 2017 --- A study has found that while standard curcumin does possess anti-inflammatory properties, BCM-95, a high-potency turmeric extract, is significantly more effective than standard curcumin in reducing colitis related disease activity and inflammatory symptoms. BCM-95 is a proprietary formulation of Arjuna Natural Extracts in a joint venture with Dolcas Biotech LLC and is composed of pure curcuminoids and essential oils from turmeric with a specific content of turmerones.

More Articles
URL : http://www.nutritioninsight.com:80/news/BioGaia-Reports-9-Sales-Growth-in-2016.html?tracking=Nutrition%20and%20Health%20News